- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 18, 2025 | 166.79M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $254.25M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $317.2M |
| Current Assets | FY 2024 · Dec 31, 2023 | $616.13M |
| Total Assets | FY 2024 · Dec 31, 2023 | $748.96M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 161.68M sh |
| Capex | FY 2024 · Dec 31, 2022 | $0 |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$114.04M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $114.85M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.34 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.34 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $369.09M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $361.58M |
| Net Income | FY 2024 · Dec 31, 2022 | −$215.98M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$223.6M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $10.17M |
| Revenue | FY 2024 · Dec 31, 2022 | $517.24M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $540.89M |